Additional Opportunities

The market opportunities for our host-targeted therapies can be expanded for use as adjunct therapy and as as anti-infective agents. Targets include:

There is a clear unmet need for treatments which are not susceptible to the rapid development of resistance and are effective against a wide variety of infections. Support for the expansion of our market opportunities comes from the list of competitors who are using immunomodulation therapy to develop novel antibiotics which are not bactericidal, but act by modulating the host’s immune response.